We thank Dr. Xiang Zhang and colleagues for their interest in and comments on our study. Our article provided a detailed exploration of the role of the gut microbiota and the Lactobacillus reuteri–indole-3-lactic acid pathway in transarterial chemoembolization–induced liver injury (TACE-LI), and we appreciate the constructive discussion this work has generated.
Journal of Hepatology published a clinical update in Research Highlights on 13 Jan 2026.
The item focuses on Reply to: “Reassessing the L.
reuteri/indole-3-lactic acid pathway in TACE-related liver injury”.
Review the original article for the full source wording and details.